According to Marksans Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.614. At the end of 2023 the company had a P/S ratio of 3.40.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.40 | 167.4% |
2022 | 1.27 | -27.58% |
2021 | 1.76 | -4.28% |
2020 | 1.84 | 179.79% |
2019 | 0.6563 | -45.13% |
2018 | 1.20 | -34.97% |
2017 | 1.84 | -9.57% |
2016 | 2.03 | -58.45% |
2015 | 4.90 | 67.25% |
2014 | 2.93 | 165.25% |
2013 | 1.10 |